DK3630977T3 - Fremgangsmåder og sammensætninger til at fremme produktionen af proteiner indeholdende ikke-naturlige aminosyrer - Google Patents
Fremgangsmåder og sammensætninger til at fremme produktionen af proteiner indeholdende ikke-naturlige aminosyrer Download PDFInfo
- Publication number
- DK3630977T3 DK3630977T3 DK18734359.5T DK18734359T DK3630977T3 DK 3630977 T3 DK3630977 T3 DK 3630977T3 DK 18734359 T DK18734359 T DK 18734359T DK 3630977 T3 DK3630977 T3 DK 3630977T3
- Authority
- DK
- Denmark
- Prior art keywords
- promoting
- compositions
- production
- methods
- amino acids
- Prior art date
Links
- 150000001413 amino acids Chemical class 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 230000001737 promoting effect Effects 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2875—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF/TNF superfamily, e.g. CD70, CD95L, CD153, CD154
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0681—Cells of the genital tract; Non-germinal cells from gonads
- C12N5/0682—Cells of the female genital tract, e.g. endometrium; Non-germinal cells from ovaries, e.g. ovarian follicle cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/93—Ligases (6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y601/00—Ligases forming carbon-oxygen bonds (6.1)
- C12Y601/01—Ligases forming aminoacyl-tRNA and related compounds (6.1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPRs]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
- C12N2501/48—Regulators of apoptosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/106—Plasmid DNA for vertebrates
- C12N2800/107—Plasmid DNA for vertebrates for mammalian
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Reproductive Health (AREA)
- Public Health (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762514754P | 2017-06-02 | 2017-06-02 | |
| PCT/US2018/035764 WO2018223108A1 (en) | 2017-06-02 | 2018-06-02 | Methods and compositions for promoting non-natural amino acid-containing protein production |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3630977T3 true DK3630977T3 (da) | 2024-04-15 |
Family
ID=62749186
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK18734359.5T DK3630977T3 (da) | 2017-06-02 | 2018-06-02 | Fremgangsmåder og sammensætninger til at fremme produktionen af proteiner indeholdende ikke-naturlige aminosyrer |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US11851662B2 (da) |
| EP (2) | EP3630977B1 (da) |
| JP (2) | JP7245786B2 (da) |
| KR (2) | KR20240063184A (da) |
| CN (2) | CN117286182A (da) |
| AU (1) | AU2018275152A1 (da) |
| BR (1) | BR112019025476A2 (da) |
| CA (1) | CA3065137A1 (da) |
| DK (1) | DK3630977T3 (da) |
| FI (1) | FI3630977T3 (da) |
| HR (1) | HRP20240344T1 (da) |
| IL (1) | IL270906A (da) |
| LT (1) | LT3630977T (da) |
| MX (2) | MX2019014286A (da) |
| MY (1) | MY202215A (da) |
| NZ (1) | NZ760107A (da) |
| PT (1) | PT3630977T (da) |
| RS (1) | RS65370B1 (da) |
| SI (1) | SI3630977T1 (da) |
| WO (1) | WO2018223108A1 (da) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117924503A (zh) | 2018-03-29 | 2024-04-26 | Ambrx公司 | 人源化抗前列腺特异性膜抗原(psma)抗体药物缀合物 |
| CN111117944B (zh) * | 2019-11-22 | 2022-05-24 | 中农威特生物科技股份有限公司 | 一种用于规模化悬浮培养的抗凋亡mdck宿主细胞株及其建立方法 |
| CN112375774A (zh) * | 2020-10-26 | 2021-02-19 | 浙江新码生物医药有限公司 | 一种重组蛋白表达用工程菌株的构建方法 |
| CN112575005A (zh) * | 2021-01-04 | 2021-03-30 | 昆明理工大学 | 一种提高烟草重金属镉胁迫抗性和降低镉富集的方法 |
| WO2023202967A1 (en) * | 2022-04-19 | 2023-10-26 | F. Hoffmann-La Roche Ag | Improved production cells |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1456360T3 (da) | 2001-04-19 | 2015-08-31 | Scripps Research Inst | Fremgangsmåder og sammensætning til fremstiling af ortogonale TRNA-aminoacyl-TRNA-syntetasepar |
| US7642085B2 (en) | 2002-12-22 | 2010-01-05 | The Scripps Research Institute | Protein arrays |
| CN102618605B (zh) | 2003-06-18 | 2015-09-02 | 斯克利普斯研究院 | 非天然活性氨基酸遗传密码增加 |
| CN101160525A (zh) | 2003-06-18 | 2008-04-09 | 斯克利普斯研究院 | 非天然活性氨基酸遗传密码增加 |
| EP1836298B1 (en) | 2004-12-22 | 2012-01-18 | Ambrx, Inc. | COMPOSITIONS OF AMINOACYL-tRNA SYNTHETASE AND USES THEREOF |
| AU2005335491B2 (en) | 2005-08-18 | 2010-11-25 | Ambrx, Inc. | Compositions of tRNA and uses thereof |
| PT2339014E (pt) * | 2005-11-16 | 2015-10-13 | Ambrx Inc | Métodos e composições compreendendo aminoácidos não-naturais |
| EP1968635B1 (en) | 2005-12-14 | 2014-09-17 | Ambrx, Inc. | Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides |
| AU2007292891B2 (en) * | 2006-09-08 | 2012-04-12 | Ambrx, Inc. | Site specific incorporation of non-natural amino acids by vertebrate cells |
| WO2008030614A2 (en) | 2006-09-08 | 2008-03-13 | Ambrx, Inc. | Suppressor trna transcription in vertebrate cells |
| WO2008030613A2 (en) | 2006-09-08 | 2008-03-13 | Ambrx, Inc. | Hybrid suppressor trna for vertebrate cells |
| WO2008073184A2 (en) | 2006-10-18 | 2008-06-19 | The Scripps Research Institute | Genetic incorporation of unnatural amino acids into proteins in mammalian cells |
| US8183037B2 (en) * | 2007-04-13 | 2012-05-22 | The Salk Institute For Biological Studies | Methods of genetically encoding unnatural amino acids in eukaryotic cells using orthogonal tRNA/synthetase pairs |
| TW200914043A (en) | 2007-04-30 | 2009-04-01 | Mj Biolog Inc | PRRSV GP5 based compositions and methods |
| GB0721291D0 (en) * | 2007-10-30 | 2007-12-12 | Medical Res Council | Methods and compositions |
| CA2893175C (en) * | 2008-06-10 | 2016-09-06 | Sangamo Biosciences, Inc. | Methods and compositions for generation of bax- and bak-deficient cell lines |
| WO2010141851A1 (en) | 2009-06-05 | 2010-12-09 | Salk Institute For Biological Studies | Improving unnatural amino acid incorporation in eukaryotic cells |
| CN104244989A (zh) | 2012-02-29 | 2014-12-24 | Ambrx公司 | 含有新颖前药的分子组合物和其用途 |
| EP2858676B1 (en) | 2012-06-07 | 2019-03-13 | Ambrx, Inc. | Prostate-specific membrane antigen antibody drug conjugates |
| CN104619350A (zh) | 2012-06-14 | 2015-05-13 | Ambrx公司 | 结合到核受体配体多肽的抗psma抗体 |
| KR102190832B1 (ko) | 2012-06-19 | 2020-12-15 | 암브룩스, 인코포레이티드 | 항cd70 항체 약물 컨쥬게이트 |
| GB201419109D0 (en) * | 2014-10-27 | 2014-12-10 | Medical Res Council | Incorporation of unnatural amino acids into proteins |
-
2018
- 2018-06-02 RS RS20240405A patent/RS65370B1/sr unknown
- 2018-06-02 EP EP18734359.5A patent/EP3630977B1/en active Active
- 2018-06-02 NZ NZ760107A patent/NZ760107A/en unknown
- 2018-06-02 KR KR1020247014001A patent/KR20240063184A/ko active IP Right Grant
- 2018-06-02 CN CN202311164969.8A patent/CN117286182A/zh active Pending
- 2018-06-02 CN CN201880049275.0A patent/CN110959041B/zh active Active
- 2018-06-02 MX MX2019014286A patent/MX2019014286A/es unknown
- 2018-06-02 BR BR112019025476-5A patent/BR112019025476A2/pt unknown
- 2018-06-02 WO PCT/US2018/035764 patent/WO2018223108A1/en active Search and Examination
- 2018-06-02 US US16/958,152 patent/US11851662B2/en active Active
- 2018-06-02 CA CA3065137A patent/CA3065137A1/en active Pending
- 2018-06-02 FI FIEP18734359.5T patent/FI3630977T3/fi active
- 2018-06-02 DK DK18734359.5T patent/DK3630977T3/da active
- 2018-06-02 AU AU2018275152A patent/AU2018275152A1/en active Pending
- 2018-06-02 LT LTEPPCT/US2018/035764T patent/LT3630977T/lt unknown
- 2018-06-02 HR HRP20240344TT patent/HRP20240344T1/hr unknown
- 2018-06-02 JP JP2019565862A patent/JP7245786B2/ja active Active
- 2018-06-02 PT PT187343595T patent/PT3630977T/pt unknown
- 2018-06-02 SI SI201831076T patent/SI3630977T1/sl unknown
- 2018-06-02 KR KR1020197038544A patent/KR102662379B1/ko active IP Right Grant
- 2018-06-02 EP EP24158417.6A patent/EP4382124A2/en active Pending
- 2018-06-02 MY MYPI2019007098A patent/MY202215A/en unknown
-
2019
- 2019-11-25 IL IL270906A patent/IL270906A/en unknown
- 2019-11-28 MX MX2023004927A patent/MX2023004927A/es unknown
-
2023
- 2023-03-13 JP JP2023038441A patent/JP2023075254A/ja active Pending
- 2023-11-10 US US18/506,836 patent/US20240167044A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR102662379B1 (ko) | 2024-04-29 |
| LT3630977T (lt) | 2024-04-25 |
| PT3630977T (pt) | 2024-04-24 |
| JP2023075254A (ja) | 2023-05-30 |
| MY202215A (en) | 2024-04-17 |
| WO2018223108A1 (en) | 2018-12-06 |
| IL270906A (en) | 2020-01-30 |
| SI3630977T1 (sl) | 2024-05-31 |
| US11851662B2 (en) | 2023-12-26 |
| BR112019025476A2 (pt) | 2020-06-23 |
| KR20200011979A (ko) | 2020-02-04 |
| FI3630977T3 (fi) | 2024-04-24 |
| MX2019014286A (es) | 2020-01-27 |
| CN110959041A (zh) | 2020-04-03 |
| RS65370B1 (sr) | 2024-04-30 |
| JP7245786B2 (ja) | 2023-03-24 |
| EP4382124A2 (en) | 2024-06-12 |
| EP3630977A1 (en) | 2020-04-08 |
| NZ760107A (en) | 2024-03-22 |
| US20210017527A1 (en) | 2021-01-21 |
| CN110959041B (zh) | 2023-09-29 |
| AU2018275152A1 (en) | 2020-01-16 |
| MX2023004927A (es) | 2023-05-17 |
| HRP20240344T1 (hr) | 2024-05-24 |
| KR20240063184A (ko) | 2024-05-09 |
| US20240167044A1 (en) | 2024-05-23 |
| CA3065137A1 (en) | 2018-12-06 |
| JP2020522247A (ja) | 2020-07-30 |
| EP3630977B1 (en) | 2024-02-21 |
| CN117286182A (zh) | 2023-12-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3601533T3 (da) | Fremgangsmåder til frembringelse af tumorinfiltrerende lymfocytter og anvendelser af samme i immunoterapi | |
| DK3303317T3 (da) | Fremgangsmåder og sammensætninger til inhibering af interaktionen af menin med MLL-proteiner | |
| DK3630977T3 (da) | Fremgangsmåder og sammensætninger til at fremme produktionen af proteiner indeholdende ikke-naturlige aminosyrer | |
| DK3272867T3 (da) | Anvendelse af programmerbare dna-bindingsproteiner til forbedring af målrettet genommodifikation | |
| DK3761980T3 (da) | Aminosyreforbindelser og fremgangsmåder til anvendelse | |
| DK3298043T3 (da) | SIRP-polypeptidsammensætninger og fremgangsmåder til anvendelse | |
| DK3882357T3 (da) | Fremgangsmåder og sammensætninger til analyse af nukleinsyrer | |
| DK3240895T3 (da) | Sammensætninger og fremgangsmåder til proteinglykosylering | |
| DK3232806T3 (da) | Opløsning af denatureret ærteprotein og anvendelser deraf til dannelse af mikropartikler | |
| DK3649104T3 (da) | Fremgangsmåde til fremstilling af langkædede aminosyrer og dibasiske syrer | |
| DK3565579T3 (da) | Pd1-41bbl-fusionsprotein og fremgangsmåder til anvendelse deraf | |
| DK3201336T3 (da) | Fremgangsmåder til ekstrahering og oprensning af ikke-denaturerede proteiner | |
| DK3393655T3 (da) | Fenfluramin-sammensætninger og fremgangsmåder til fremstilling af samme | |
| DK3096798T3 (da) | Plasmakallikreinbindende proteiner og anvendelser deraf til behandling af hereditært angioødem | |
| DK3565828T3 (da) | Sirp1 alpha-41bbl-fusionsprotein og fremgangsmåder til anvendelse deraf | |
| GB201419109D0 (en) | Incorporation of unnatural amino acids into proteins | |
| DK3287523T3 (da) | Fremgangsmåde til sekretorisk fremstilling af protein | |
| DK3389636T3 (da) | Sammensætninger og fremgangsmåder til fremstilling af proteinmikropartikler | |
| IL253971B (en) | A method for purifying albumin-fusion proteins | |
| MA53498A (fr) | Production de protéines recombinantes | |
| DK3380496T3 (da) | Forbedret proteinproduktion og fremgangsmåder hertil | |
| DK3313864T3 (da) | Rekombinante virusvektorer indeholdende prrsv minor protein og fremgangsmåder til fremstilling og anvendelse deraf | |
| DK3390427T3 (da) | Fremgangsmåde til fremstilling af degarelix og dets mellemprodukter | |
| DK3452424T3 (da) | Fremgangsmåde og anlæg til fremstilling af cement | |
| DK3331694T3 (da) | Stort formet letvægtsmateriale og fremgangsmåde til fremstilling deraf |